Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
Clinical trial NCT04804605 · COMPLETED
Trial details
- NCT number
- NCT04804605
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2024-05-28
- Enrollment
- 1220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.